PDS Biotechnology Corp.
(NASDAQ : PDSB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc.
-1.15%69.462.3%$1252.30m
PFEPfizer Inc.
-0.37%42.590.9%$980.64m
JNJJohnson & Johnson
-1.31%132.950.7%$912.32m
MRKMerck & Co., Inc.
0.00%80.960.6%$789.38m
BMYBristol-Myers Squibb Company
0.49%44.411.4%$660.04m
LLYEli Lilly and Company
0.14%108.621.0%$355.20m
NVSNovartis AG Sponsored ADR
-0.53%88.800.2%$142.73m
GSKGlaxoSmithKline plc Sponsored ADR
0.56%41.130.2%$91.54m
AZNAstraZeneca PLC Sponsored ADR
-0.03%40.211.2%$91.46m
SNYSanofi Sponsored ADR
-0.07%41.620.2%$72.48m
NVONovo Nordisk A/S Sponsored ADR Class B
0.23%47.760.1%$63.59m
LCILannett Company, Inc.
-2.32%5.7036.6%$4.09m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%1.871.6%$0.29m
EPIXESSA Pharma Inc
15.91%2.690.1%$0.01m

Company Profile

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded on March 15, 2019 and is headquartered in Berkeley Heights, NJ.